Scinus
Desconocido
iP-OSTEO: Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds
SCINUS HOLDING BV
participó en un
H2020:
H2020-MSCA-RISE-2018
IP-OSTEO project focuses on development of novel cell-based scaffolds for bone and cartilage repair in patients with poor regenerative capac...
2018-11-14 - 2024-07-31 | Financiado
2018-11-14 - 2024-07-31 | Financiado
MUSIC: Multisystem Cell Therapy for Improvement of Urinary Continence
SCINUS HOLDING BV
participó en un
H2020:
H2020-SC1-2016-2017
"Stress Urinary Incontinence (SUI) is a disease affecting over 200 million people worldwide. It represents a condition with a prevalence of...
2016-11-29 - 2022-03-31 | Financiado
2016-11-29 - 2022-03-31 | Financiado
STELLAR: Stem cell based therapy for kidney repair
SCINUS HOLDING BV
participó en un
FP7:
Chronic kidney disease (CKD) affects 8% of the European population and ultimately results in renal failure due to progressive fibrosis. CDK...
Financiado
Financiado
* No se disponen de datos de la empresa actual.